Edwards Lifesciences (EW) Short-term Investments (2011 - 2026)

Edwards Lifesciences has reported Short-term Investments for 16 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 61.76% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 61.76% YoY), and the FY2025 full-year result was $1.3 billion, up 38.42% from the prior year.
• Short-term Investments for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
• The five-year high for Short-term Investments was $1.3 billion in Q4 2025, with the low at $317.7 million in Q2 2022.
• Average Short-term Investments over 5 years is $662.3 million, with a median of $490.9 million recorded in 2022.
• Peak annual rise in Short-term Investments reached 197.31% in 2022, while the deepest fall reached 26.11% in 2022.
• Tracing EW's Short-term Investments over 5 years: stood at $446.3 million in 2022, then advanced by 12.14% to $500.5 million in 2023, then soared by 85.95% to $930.7 million in 2024, then surged by 38.42% to $1.3 billion in 2025, then dropped by 4.84% to $1.2 billion in 2026.
• The last three Short-term Investments figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.

Peer Comparison